Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309–318 doi:10.1179/2047773215Y.0000000030 PubMed PMID: 26343252; PubMed Central PMCID: PMC4768623

Article  PubMed  PubMed Central  Google Scholar 

Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA et al (2023) Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare 11(13):1946. https://doi.org/10.3390/healthcare11131946 PubMed PMID: 37444780; PubMed Central PMCID: PMC10340576

Article  PubMed  PubMed Central  Google Scholar 

Vázquez-López R, Solano-Gálvez SG, Juárez Vignon-Whaley JJ, Abello Vaamonde JA, Padró Alonzo LA, Rivera Reséndiz A et al (2020) Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics (Basel, Switzerland) 9(4):205. https://doi.org/10.3390/antibiotics9040205

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reina R, León-Moya C, Garnacho-Montero J (2022) Treatment of Acinetobacter baumannii severe infections. Med Intensiva Engl Ed 46(12):700–10. https://doi.org/10.1016/j.medine.2022.08.007

Article  CAS  PubMed  Google Scholar 

Iovleva A, Fowler VG, Doi Y (2025) Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections. Drugs 85(1):21–40. https://doi.org/10.1007/s40265-024-02104-6

Article  PubMed  Google Scholar 

Dubey V, Reza N, Hope W (2025) Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen. Munita JM, editor. Clin Microbiol Rev. ;38(3):e00279-24. https://doi.org/10.1128/cmr.00279-24

Wise MG, Karlowsky JA, Mohamed N, Hermsen ED, Kamat S, Townsend A et al (2024) Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022. J Glob Antimicrob Resist 37:168–175. https://doi.org/10.1016/j.jgar.2024.03.020

Article  CAS  PubMed  Google Scholar 

Isler B, Doi Y, Bonomo RA, Paterson DL (2019) New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother 63(1):e01110-18. https://doi.org/10.1128/AAC.01110-18

Article  PubMed  Google Scholar 

Karah N, Nemec A, Uhlin BE (2025) History of the taxonomy of Acinetobacter: the emergence of hospital-adapted species of global health concern. Int J Syst Evol Microbiol. https://doi.org/10.1099/ijsem.0.006983

Article  PubMed  PubMed Central  Google Scholar 

Chusri S, Chongsuvivatwong V, Rivera JI, Silpapojakul K, Singkhamanan K, McNeil E et al (2014) Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob Agents Chemother 58(7):4172–4179. https://doi.org/10.1128/AAC.02992-14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Wang J, Fu Y, Ruan Z, Yu Y (2016) Acinetobacter seifertii Isolated from China: Genomic Sequence and Molecular Epidemiology Analyses. Med (Baltim) 95(9):e2937. https://doi.org/10.1097/MD.0000000000002937

Article  CAS  Google Scholar 

Mardhiyah AK, Saharman YR, Sjatha F (2024) Mobile Genetic Elements Contributing to Carbapenem Resistance in Acinetobacter baumannii: Current Insights. EKSAKTA Berk Ilm Bid MIPA 25(04):382–398. https://doi.org/10.24036/eksakta/vol25-iss04/534

Article  Google Scholar 

Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A (2021) Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens 10(3):373. https://doi.org/10.3390/pathogens10030373

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, Saldaña-Padilla A, Hernández-Cortez C, Loyola-Cruz MA et al (2022) Evasion of antimicrobial activity in Acinetobacter baumannii by target site modifications: an effective resistance mechanism. Int J Mol Sci 23(12):6582. https://doi.org/10.3390/ijms23126582

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sayid R, Van Den Hurk AWM, Rothschild-Rodriguez D, Herrema H, De Jonge PA, Nobrega FL (2024) Characteristics of phage-plasmids and their impact on microbial communities. Santini JM, editor. Essays Biochem. ;68(5):583–92. https://doi.org/10.1042/EBC20240014

Pfeifer E, Bonnin RA, Rocha EPC (2022) Phage-Plasmids Spread Antibiotic Resistance Genes through Infection and Lysogenic Conversion. Goldman GH, editor. mBio. ;13(5):e01851-22. https://doi.org/10.1128/mbio.01851-22

MacNair CR, Rutherford ST, Tan MW (2024) Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol 22(5):262–275. https://doi.org/10.1038/s41579-023-00993-0

Article  CAS  PubMed  Google Scholar 

Getz LJ, Patel PH, Maxwell KL (2025) A solution to the postantibiotic era: phages as precision medicine. Curr Opin Microbiol 86:102613. https://doi.org/10.1016/j.mib.2025.102613

Article  CAS  PubMed  Google Scholar 

Palaniappan R, Dayanithi G Therapeutic Efficacy of Bacteriophages. In: Bacteriophages in Therapeutics [Internet]. IntechOpen; 2021 [cited 2026 Mar 14]. Available from: https://www.intechopen.com/chapters/76569https://doi.org/10.5772/intechopen.97619

Monteiro R, Pires DP, Costa AR, Azeredo J (2019) Phage therapy: going temperate? Trends Microbiol 27(4):368–78. https://doi.org/10.1016/j.tim.2018.10.008

Article  CAS  PubMed  Google Scholar 

Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L et al (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61(10):e00954-17. https://doi.org/10.1128/AAC.00954-17

Article  PubMed  PubMed Central  Google Scholar 

Liu M, Hernandez-Morales A, Clark J, Le T, Biswas B, Bishop-Lilly KA et al (2022) Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy. Nat Commun 13(1):3776. https://doi.org/10.1038/s41467-022-31455-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

He P, Cao F, Qu Q, Geng H, Yang X, Xu T et al (2024) Host range expansion of Acinetobacter phage vB_Ab4_Hep4 driven by a spontaneous tail tubular mutation. Front Cell Infect Microbiol 14:1301089. https://doi.org/10.3389/fcimb.2024.1301089

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Lei T, Tan Y, Huang X, Zhao W, Zou H et al (2025) Discovery, structural characteristics and evolutionary analyses of functional domains in Acinetobacter baumannii phage tail fiber/spike proteins. BMC Microbiol 25(1):73. https://doi.org/10.1186/s12866-025-03790-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Islam MM, Mahbub NU, Shin WS, Oh MH (2024) Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii. Front Cell Infect Microbiol 14:1462620. https://doi.org/10.3389/fcimb.2024.1462620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Timoshina OY, Kasimova AA, Shneider MM, Matyuta IO, Nikolaeva AY, Evseev PV et al (2023) Friunavirus phage-encoded depolymerases specific to different capsular types of Acinetobacter baumannii. Int J Mol Sci 24(10):9100. https://doi.org/10.3390/ijms24109100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S et al (2020) Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis 7(9):ofaa389. https://doi.org/10.1093/ofid/ofaa389

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin J, Dai G, Zhang L, Xu P, Zhao P, Zhou Y et al (2025) Case Report: Bacteriophage-antibiotic therapy for extensively drug-resistant Acinetobacter baumannii in critically ill patient with respiratory infection. Front Med 12:1716306. https://doi.org/10.3389/fmed.2025.1716306

Article  Google Scholar 

Qu J, Zou J, Zhang J, Qu J, Lu H (2024) Phage therapy for extensively drug resistant Acinetobacter baumannii infection: case report and in vivo evaluation of the distribution of phage and the impact on gut microbiome. Front Med 11:1432703. https://doi.org/10.3389/fmed.2024.1432703

Article  Google Scholar 

Torres-Barceló C (2018) Phage Therapy Faces Evolutionary Challenges. Viruses 10(6):323. https://doi.org/10.3390/v10060323

Article  PubMed  PubMed Central